192 related articles for article (PubMed ID: 36297639)
1. Antifungal Nail Lacquer for Enhanced Transungual Delivery of Econazole Nitrate.
Puri V; Savla R; Chen K; Robinson K; Virani A; Michniak-Kohn B
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297639
[TBL] [Abstract][Full Text] [Related]
2. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
Khattab A; Shalaby S
AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Ungual Permeation of Terbinafine HCl Delivered Through Liposome-Loaded Nail Lacquer Formulation Optimized by QbD Approach.
Shah VH; Jobanputra A
AAPS PharmSciTech; 2018 Jan; 19(1):213-224. PubMed ID: 28681334
[TBL] [Abstract][Full Text] [Related]
4. Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation.
Dehari D; Mehata AK; Priya V; Parbat D; Kumar D; Srivastava AK; Singh S; Agrawal AK
AAPS PharmSciTech; 2022 Jun; 23(6):175. PubMed ID: 35750993
[TBL] [Abstract][Full Text] [Related]
5. Application of central composite design for the optimization of itraconazole loaded nail lacquer formulation.
Rahman A; Aqil M; Ahad A; Imam SS; Qadir A; Ali A
3 Biotech; 2021 Jul; 11(7):324. PubMed ID: 34194908
[TBL] [Abstract][Full Text] [Related]
6. Development of ciclopirox nail lacquer with enhanced permeation and retention.
Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
[TBL] [Abstract][Full Text] [Related]
7. Terbinafine hydrochloride nail lacquer for the management of onychomycosis: formulation, characterization and in vitro evaluation.
Thatai P; Sapra B
Ther Deliv; 2018 Feb; 9(2):99-119. PubMed ID: 29325509
[TBL] [Abstract][Full Text] [Related]
8. Transungual delivery of ketoconazole using novel lacquer formulation.
Hafeez F; Hui X; Chiang A; Hornby S; Maibach H
Int J Pharm; 2013 Nov; 456(2):357-61. PubMed ID: 24029171
[TBL] [Abstract][Full Text] [Related]
9. Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis.
Patel MM; Vora ZM
Drug Deliv Transl Res; 2016 Jun; 6(3):263-75. PubMed ID: 26926242
[TBL] [Abstract][Full Text] [Related]
10. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
11. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
[TBL] [Abstract][Full Text] [Related]
12. Onychomycosis: Potential of Nail Lacquers in Transungual Delivery of Antifungals.
Akhtar N; Sharma H; Pathak K
Scientifica (Cairo); 2016; 2016():1387936. PubMed ID: 27123362
[TBL] [Abstract][Full Text] [Related]
13. Quality by Design Guided Development of Polymeric Nanospheres of Terbinafine Hydrochloride for Topical Treatment of Onychomycosis Using a Nano-Gel Formulation.
Puri V; Froelich A; Shah P; Pringle S; Chen K; Michniak-Kohn B
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297605
[TBL] [Abstract][Full Text] [Related]
14. Hydroxypropyl chitosan nail lacquer of ciclopirox-PLGA nanocapsules for augmented in vitro nail plate absorption and onychomycosis treatment.
Gaballah EY; Borg TM; Mohamed EA
Drug Deliv; 2022 Dec; 29(1):3304-3316. PubMed ID: 36372978
[TBL] [Abstract][Full Text] [Related]
15. In Silico Drug Screening Based Development of Novel Formulations for Onychomycosis Management.
Fatima M; Monawwar S; Mohapatra S; Alex TS; Ahmed A; Taleuzzaman M; Ali A; Ansari MJ; Mirza MA; Iqbal Z
Gels; 2021 Nov; 7(4):. PubMed ID: 34842710
[TBL] [Abstract][Full Text] [Related]
16. A drug-in-adhesive anti-onychomycotic nail patch: Influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy.
Rizi K; Xu K; Begum T; Faull J; Bhakta S; Murdan S
Int J Pharm; 2022 Feb; 614():121437. PubMed ID: 34973408
[TBL] [Abstract][Full Text] [Related]
17. Polyurethanes as New Excipients in Nail Therapeutics.
Valdes BSG; Serro AP; Marto J; Santos RGD; Gómez EC; Otero-Espinar FJ; Bordado JM; Ribeiro HM
Pharmaceutics; 2018 Dec; 10(4):. PubMed ID: 30551686
[TBL] [Abstract][Full Text] [Related]
18. Hydroxypropyl- β -cyclodextrin: A Novel Transungual Permeation Enhancer for Development of Topical Drug Delivery System for Onychomycosis.
Chouhan P; Saini TR
J Drug Deliv; 2014; 2014():950358. PubMed ID: 25177500
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies.
Agrawal V; Patel R; Patel M; Thanki K; Mishra S
Colloids Surf B Biointerfaces; 2021 May; 201():111652. PubMed ID: 33740733
[TBL] [Abstract][Full Text] [Related]
20. A Novel Apremilast Nail Lacquer Formulation for the Treatment of Nail Psoriasis.
Kushwaha AS; Repka MA; Narasimha Murthy S
AAPS PharmSciTech; 2017 Nov; 18(8):2949-2956. PubMed ID: 28455829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
